Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2003
05/20/2003US6566360 2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors
05/20/2003US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/20/2003US6566354 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
05/20/2003US6566352 Administering alpha -hydroxy-2-methylene-19-nor-pregnacalciferol compound for therapy of psoriasis
05/20/2003US6566324 Preventing airway mucus production by administration of EGF-R antagonists
05/20/2003US6565895 Side-effect reduction of anti-cancer therapy
05/20/2003US6565885 Methods of spray drying pharmaceutical compositions
05/20/2003US6565831 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/20/2003CA2234239C Indole carbamates as leukotriene antagonists
05/20/2003CA2117059C Pyrido-pyridazinone and pyridazinthione compounds
05/20/2003CA2070524C Retinoids substituted by a dithiane cyclic and their use, process for the preparation of these compounds, cosmetic and pharmaceutical compositions containing them and therapeutical use of said compositions
05/15/2003WO2003040371A1 Novel g protein-coupled receptor protein and dna thereof
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003040138A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040137A1 Dimeric compounds and their use as anti-viral agents
05/15/2003WO2003040115A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003WO2003040107A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/15/2003WO2003040106A1 Preparation and use of substituted imidazoles
05/15/2003WO2003040102A1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors
05/15/2003WO2003040101A1 Anthranilic acid amides and pharmaceutical use thereof
05/15/2003WO2003040099A1 Preparation of benzosuberonylpiperidine compounds
05/15/2003WO2003040098A1 Novel metalloproteinase inhibitors
05/15/2003WO2003040097A1 Nitrogenous compounds, production process, and method of use thereof
05/15/2003WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003WO2003040080A2 Lipoxin a4 analogs
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039566A2 Methods of treatment in situ in the lungs of mammals
05/15/2003WO2003039548A1 Hydrazono-malonitriles
05/15/2003WO2003039546A1 New uses for anti-malarial therapeutic agents
05/15/2003WO2003039544A1 Naphtyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
05/15/2003WO2003039533A1 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
05/15/2003WO2003039473A2 Method for treating or preventing inflammatory diseases
05/15/2003WO2003039472A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003WO2003039469A2 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
05/15/2003WO2003039451A2 Thiazole pyridazinones as adenosine antagonists
05/15/2003WO2003039446A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
05/15/2003WO2003039439A2 Deuterated pyrazolopyrimidinones and drugs containing said compounds
05/15/2003WO2003039231A2 Compounds and methods for treating transplant rejection
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death
05/15/2003WO2002064795A3 Putative human enzymes
05/15/2003WO2002057298A3 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
05/15/2003WO2002047672A3 Treatment of cystic fibrosis with alkalinizing agents
05/15/2003WO2002038181A3 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect
05/15/2003WO2002026781A9 Ige receptor antagonists
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092897 Antigen composition against mycoplasma
05/15/2003US20030092771 Inhibitors of transcription factor NF-kappaB
05/15/2003US20030092762 Anti-inflammatory nitro and thia-fatty acids
05/15/2003US20030092736 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092717 Inhibitors of p38 kinase
05/15/2003US20030092713 Antiinflammatory agents; antiallergens; psychological disorders
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092663 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
05/15/2003US20030092633 Preventing desensitization of receptors
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030091611 Antiproliferative agents ; antiinflammatory agents; insertable stent
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003US20030091509 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2470271A1 Deuterated pyrazolopyrimidinones and drugs containing said compounds
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465894A1 Method for treating or preventing inflammatory diseases
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310797A2 Method of monitoring neuroprotective treatment
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310247A1 (+)-ephedrine as a sympathomimetic drug
05/14/2003EP1310243A1 Novel formulation
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309593A2 Substituted pyrazoles
05/14/2003EP1309592A2 Substituted pyrazoles
1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 878